Kedudukan dalam Saham
#17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Harga Saham
$29.82
Disegerakkan terakhir: 2023-04-11
Perubahan (1 tahun)
0.00%
Perdagangan Neovasc Inc. (NVCN)
Harga NVCN dengan permodalan pasaran b
Modal pasaran bagi Neovasc Inc.(NVCN)
Modal Pasaran: $223.68M
Sehingga September 2026, Neovasc Inc. mempunyai modal pasaran sebanyak $223.68M. Ini menjadikan Neovasc Inc. syarikat ke-17840th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Neovasc Inc. dari 2001 hingga 2026
NVCN berbanding dengan 5 teratas yang paling popular stocks
| Harga NVCN |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.424T
|
+2,424,906.63%
|
|
|
|
|
$4.776T
|
+2,135,027.86%
|
|
|
|
|
$4.052T
|
+1,811,320.46%
|
|
|
|
|
$3.691T
|
+1,650,030.99%
|
|
|
|
|
$2.744T
|
+1,226,752.87%
|
